Cargando...
Interferon α/β enhances the cytotoxic response of MEK inhibition in melanoma
Drugs that inhibit the MAPK pathway have therapeutic benefit in melanoma, but responses vary between patients, for reasons that are still largely unknown. Here we aim at explaining this variability using pre- and post-MEK inhibition transcriptional profiles in a panel of melanoma cell-lines. We foun...
Guardado en:
| Publicado en: | Mol Cell |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4355234/ https://ncbi.nlm.nih.gov/pubmed/25684207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molcel.2014.12.030 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|